Source: PharmaTimes

STIVARGA: Stivarga final NICE recommendation for hepatocellular carcinoma

Bayer’s Stivarga has received a final green light from the National Institute for Health and Care Excellence (NICE) for use by the NHS to treat advanced liver cancer.

Read full article »
Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
1-25
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



STIVARGA's headquarters is in Whippany, New Jersey. STIVARGA has a revenue of $10M, and 10 employees.